alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-27-1997
<PERIOD-END>                               SEP-27-1997
<CASH>                                       1,334,000
<SECURITIES>                                         0
<RECEIVABLES>                                  248,000
<ALLOWANCES>                                 (124,000)
<INVENTORY>                                  1,253,000
<CURRENT-ASSETS>                             3,000,000
<PP&E>                                      11,270,000
<DEPRECIATION>                             (7,565,000)
<TOTAL-ASSETS>                               8,382,000
<CURRENT-LIABILITIES>                        2,658,000
<BONDS>                                      2,085,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       210,000
<OTHER-SE>                                   3,429,000
<TOTAL-LIABILITY-AND-EQUITY>                 8,382,000
<SALES>                                     19,219,000
<TOTAL-REVENUES>                            20,320,000
<CGS>                                        9,491,000
<TOTAL-COSTS>                               19,268,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                21,000
<INTEREST-EXPENSE>                             145,000
<INCOME-PRETAX>                              1,106,000
<INCOME-TAX>                                    13,000
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,093,000
<EPS-PRIMARY>                                     1.17
<EPS-DILUTED>                                     1.08
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                               1
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     1
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       1
<CURRENT-LIABILITIES>                             8076
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        455
<COMMON>                                            65
<OTHER-SE>                                      (8595)
<TOTAL-LIABILITY-AND-EQUITY>                         1
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                    48
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  42
<INCOME-PRETAX>                                   (90)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (90)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (90)
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01
        

</TABLE>
# The NIH Director
Exhibit 4(b)


 




	
  

  	
  NUMBER
  INCORPORATED UNDER THE LAWS OF SHARES DELAWARE SERIES A 0% CONVERTIBLE
  PREFERRED STOCK, $.01 PAR VALUE STREAMLINE HEALTH SOLUTIONS, INC. This
  Certifies that SPECIMEN is the owner of fully paid and non-assessable Shares
  of the Capital Stock of the above named Corporation transferable only on the
  books of the Corporation by the holder hereof in person or by duly authorized
  Attorney upon surrender of this Certificate properly endorsed. In Witness
  Whereof, the said Corporation has caused this Certificate to be signed by its
  duly authorized officers and its Corporate Seal to be hereunto affixed this
  day of Stephen H. Murdock, Corporate Secretary Robert E. Watson, President

  






 















	
  

  	
  EXPLANATION OF
  ABBREVIATIONS The following abbreviations, when used in the inscription of
  ownership on the face of this certificate, shall be construed as if the were
  written out in full according to applicable laws or regulations.
  Abbreviations, in addition to those appearing below, may be used JT TEN As
  joint tenants with right of survivorship and TEN ENT As tenants by the
  entireties not as tenants in common UNIF GIFT MIN ACT Uniform Gifts to Minors
  Act TEN COM As tenants in common CUST Custodian for UNIF TRANS MIN ACT
  Uniform Transfers to Minors Ac For Value Received, hereby sell, assign and
  transfer unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF
  ASSIGNEE Shares represented by the within Certificate, and do hereby
  irrevocably constitute and appoint Attorney to transfer the said Shares on
  the books of the within named Corporation with full power of substitution in
  the premises. Dated 20 In presence of NEITHER THIS SECURITY NOR THE
  SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH
  THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
  STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
  ACT OF 1933, AS AMENDED (THE “SECURITIES ACT’’), AND, ACCORDINGLY,
  MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
  STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
  FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
  THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
  EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
  SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. CERTIFICATE
  FOR SHARES OF SPECIMEN Issuedto Dated NAME AS WRITTEN UPON THE FACE OF THE
  CERTIFICATE IN EVERY PARTICULAR WITHOUT ALTERATION OR ENLARGEMENT, OR ANY
  CHANGE WHATSOVER.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 3655 Introduced in Senate (IS)]

111th CONGRESS
  2d Session
                                S. 3655

     To establish a point of order against certain climate change 
                              legislation.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 27, 2010

  Mr. Johanns introduced the following bill; which was read twice and 
         referred to the Committee on Rules and Administration

_______________________________________________________________________

                                 A BILL

 
     To establish a point of order against certain climate change 
                              legislation.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. POINT OF ORDER AGAINST CLIMATE CHANGE LEGISLATION.

    (a) Point of Order.--Subject to subsection (b), it shall not be in 
order in the Senate to consider any conference report or other 
legislation that originates in the House of Representatives as a 
message, bill, amendment, or motion, or any Senate bill or related 
conference report to which the House of Representatives added a 
provision, that addresses climate change through the inclusion of a 
cap-and-trade program if the Senate has not considered and approved a 
bill addressing climate change that included such a cap-and-trade 
program.
    (b) Waiver and Appeal.--
            (1) Waiver.--Subsection (a) may be waived or suspended in 
        the Senate only by an affirmative vote of \2/3\ of the Members, 
        duly chosen and sworn.
            (2) Appeal.--An affirmative vote of \2/3\ of the Members of 
        the Senate, duly chosen and sworn, shall be required to sustain 
        an appeal of the ruling of the Chair on a point of order raised 
        under subsection (a).
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
Barnwell Industries, Inc.'s 9/30/2000 10-KSB and is qualified in its entirety
by reference to such 10-KSB filing.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                            5701
<SECURITIES>                                         0
<RECEIVABLES>                                     2172
<ALLOWANCES>                                       154
<INVENTORY>                                         81
<CURRENT-ASSETS>                                  9121
<PP&E>                                           60882
<DEPRECIATION>                                   35534
<TOTAL-ASSETS>                                   38660
<CURRENT-LIABILITIES>                             7387
<BONDS>                                           9133
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           821
<OTHER-SE>                                       11853
<TOTAL-LIABILITY-AND-EQUITY>                     38660
<SALES>                                          25330
<TOTAL-REVENUES>                                 26570
<CGS>                                             5869
<TOTAL-COSTS>                                     5869
<OTHER-EXPENSES>                                  3572
<LOSS-PROVISION>                                   (42)
<INTEREST-EXPENSE>                                 813
<INCOME-PRETAX>                                   9118
<INCOME-TAX>                                      4108
<INCOME-CONTINUING>                               5010
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      5010
<EPS-BASIC>                                       3.81
<EPS-DILUTED>                                     3.67


</TABLE>
ex10.c- opinion of counsel 072413






July 24, 2013




Board of Directors
Principal Life Insurance Company
711 High Street
Des Moines, IA  50392


RE:    Principal Life Insurance Company Separate Account B - 
Variable Annuity Contracts


Dear Board of Directors:


The Separate Account B was established by the Board of Directors of Principal Life Insurance Company as a separate account for assets applicable to variable annuity contracts.  The Board established the separate account pursuant to then existing provisions of the Code of Iowa pertaining to the establishment of separate accounts by Iowa-domiciled life insurance companies.  Principal Life Insurance Company is filing a Registration Statement on Form N-4/A with the Securities and Exchange Commission under the Securities Act of 1933 with respect to the new Principal Investment Plus Variable Annuity (for applications signed or after August 1, 2013) (the “Contract”). 


It is my opinion that:


		
	1.
	The Separate Account B is a separate account of the Company duly created and validly existing pursuant to Iowa law.




		
	2.
	The Contract, when issued in accordance with the Prospectus contained or referred to in the Registration Statement and upon compliance with applicable local law, will be the legal and binding obligation of the Company enforceable in accordance with its terms.




		
	3.
	All income and expenses and all gains and losses, whether or not realized, of the Separate Account B, shall be credited to or charged against the Separate Account B, without regard to income and expenses or gains and losses of the Company.




		
	4.
	The assets of Contracts participating in a division of the Separate Account B shall not be charged with any liabilities arising from any other business conducted by the Company.




In arriving at the foregoing opinion, I, or attorneys under my supervision, have made such examination of law and examined such records and other documents as in my judgment are necessary or appropriate. 


I consent to the filing of this opinion as an exhibit to the Registration Statement for the Contracts and to the use of my name under the caption “Legal Opinions” in the prospectus contained in the Registration Statement.


Very truly yours,


/s/ Karen E. Shaff


Karen E. Shaff
Executive Vice President
and General Counsel
[Federal Register Volume 74, Number 111 (Thursday, June 11, 2009)]
[Rules and Regulations]
[Page 27683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13749]


-----------------------------------------------------------------------

FEDERAL DEPOSIT INSURANCE CORPORATION

12 CFR Part 337


Technical Amendments to Interest Rate Restrictions on Insured 
Depository Institutions That Are Not Well Capitalized; Withdrawal

AGENCY: Federal Deposit Insurance Corporation (FDIC).

ACTION: Final rule; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Federal Deposit Insurance Corporation published in the 
Federal Register of June 3, 2009 (74 FR 26516), a final rule concerning 
Interest Rate Restrictions on Insured Depository Institutions That Are 
Not Well Capitalized. Inadvertently a draft version of the document was 
published instead of the version adopted by the FDIC Board of 
Directors. The Federal Deposit Insurance Corporation withdraws the rule 
published at 74 FR 26516. The correct version of the final rule is 
published elsewhere in this Federal Register.

DATES: Effective on June 11, 2009, the final rule amending 12 CFR part 
337 published June 3, 2009 (74 FR 26516) is withdrawn.

FOR FURTHER INFORMATION CONTACT: Christopher L. Hencke, 202-898-8839; 
E-mail: <a href="/cdn-cgi/l/email-protection#084b606d666b636d486e6c616b266f677e"><span class="__cf_email__" data-cfemail="d291bab7bcb1b9b792b4b6bbb1fcb5bda4">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Federal Deposit Insurance Corporation 
published in the Federal Register of June 3, 2009, a final rule 
concerning Interest Rate Restrictions on Insured Depository 
Institutions That Are Not Well Capitalized. Inadvertently a draft 
version of the document was published instead of the version adopted by 
the FDIC Board of Directors. This document is withdrawn and the correct 
version is published elsewhere in this Federal Register. Although the 
differences in the two versions are not extensive, the correct final 
rule is being published in its entirety to ensure clarity.

    Dated: June 5, 2009.
Robert E. Feldman,
Executive Secretary.
[FR Doc. E9-13749 Filed 6-10-09; 8:45 am]
BILLING CODE 6714-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# Science, Health, and Public Trust
II 

111TH CONGRESS 

2D SESSION S. 3513 

To amend the Internal Revenue Code of 1986 to extend for one year the 

special depreciation allowances for certain property. 

IN THE SENATE OF THE UNITED STATES 

JUNE 21, 2010 

Mr. BAUCUS (for himself and Mr. GRASSLEY) introduced the following bill; 

which was read twice and referred to the Committee on Finance 

A BILL 

To amend the Internal Revenue Code of 1986 to extend 

for one year the special depreciation allowances for certain property. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Bonus Depreciation 

5 Extension to Create Jobs Act’’. 

6 SEC. 2. EXTENSION OF SPECIAL ALLOWANCE FOR CERTAIN 

7 PROPERTY. 

8 (a) IN GENERAL.—Paragraph (2) of section 168(k) 

9 of the Internal Revenue Code of 1986 is amended— 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•S 3513 IS

1 (1) by striking ‘‘January 1, 2011’’ in subpara2 graph (A)(iv) and inserting ‘‘January 1, 2012’’, and 

3 (2) by striking ‘‘January 1, 2010’’ each place 

4 it appears and inserting ‘‘January 1, 2011’’. 

5 (b) CONFORMING AMENDMENTS.— 

6 (1) The heading for subsection (k) of section 

7 168 of such Code is amended by striking ‘‘JANUARY

8 1, 2010’’ and inserting ‘‘JANUARY 1, 2011’’. 

9 (2) The heading for clause (ii) of section 

10 168(k)(2)(B) of such Code is amended by striking 

11 ‘‘PRE-JANUARY 1, 2010’’ and inserting ‘‘PRE-JANU12 ARY 1, 2011’’. 

13 (3) Subparagraph (D) of section 168(k)(4) of 

14 such Code is amended by striking ‘‘and’’ at the end 

15 of clause (ii), by striking the period at the end of 

16 clause (iii) and inserting a comma, and by adding at 

17 the end the following new clauses: 

18 ‘‘(iv) ‘January 1, 2011’ shall be sub19 stituted for ‘January 1, 2012’ in subpara20 graph (A)(iv) thereof, and 

21 ‘‘(v) ‘January 1, 2010’ shall be sub22 stituted for ‘January 1, 2011’ each place it 

23 appears in subparagraph (A) thereof.’’. 


smartinez on DSKB9S0YB1PROD with BILLS
3 

•S 3513 IS

1 (4) Subparagraph (B) of section 168(l)(5) of 

2 such Code is amended by striking ‘‘January 1, 

3 2010’’ and inserting ‘‘January 1, 2011’’. 

4 (5) Subparagraph (C) of section 168(n)(2) of 

5 such Code is amended by striking ‘‘January 1, 

6 2010’’ and inserting ‘‘January 1, 2011’’. 

7 (6) Subparagraph (D) of section 1400L(b)(2) 

8 of such Code is amended by striking ‘‘January 1, 

9 2010’’ and inserting ‘‘January 1, 2011’’. 

10 (7) Subparagraph (B) of section 1400N(d)(3) 

11 of such Code is amended by striking ‘‘January 1, 

12 2010’’ and inserting ‘‘January 1, 2011’’. 

13 (c) EFFECTIVE DATE.—The amendments made by 

14 this section shall apply to property placed in service after 

15 December 31, 2009. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
Exhibit 21.1LISTING OF SUBSIDIARIESJURISDICTION OFSUBSIDIARYORGANIZATIONBio-Rad Laboratories Pty. LimitedAustraliaBio-Rad Laboratories Ges.m.b.H.AustriaDiaMed Österreich G.m.b.H.AustriaBio-Rad Laboratories S.A.- N.V.BelgiumResearch Specialties for Laboratories N.V.BelgiumDiaMed Eurogen N.V.BelgiumBio-Rad Laboratorios Brasil Ltda.BrazilDiaMed Latino America S.A.BrazilBio-Metrics Properties, LimitedCalifornia, USABio-Rad Laboratories (Israel) Inc.California, USABio-Rad Pacific LimitedCalifornia, USABlackhawk Biosystems, Inc.California, USABio-Rad Laboratories (Canada) LimitedCanadaBio-Rad Laboratories (Shanghai) LimitedChinaBio-Rad (Shanghai) Life Science R&D Co. Ltd.ChinaBio-Rad Spol. S.R.O.Czech RepublicBio-Rad Export LLCDelaware, USABio-Metrics Ltd.Delaware, USABio-Rad Holdings LLCDelaware, USAMJ Bioworks, Inc.Delaware, USADiaMed Baltica OuEstoniaBio-Rad France HoldingFranceBio-Rad France Holding 2FranceBio-Rad PasteurFranceADIL Instruments SASFranceBio-Rad Laboratories SASFranceBio-Rad Verdot SASFranceBio-Rad SNCFranceCentral Labo Europe SASFranceDiaMed France SAFranceNoviloire SAFranceDiaMed Instruments Logistics SASFranceDiaMed Fennica OyFinlandBio-Rad Laboratories G.m.b.H.GermanyBio-Rad German Holding Company G.m.b.H.GermanyDiaMed Diagnostika Deutschland G.m.b.H.GermanyBio-Rad Laboratories M E.P.E.GreeceBio-Rad Hungary Trading Ltd.Hungary  1       Exhibit 21.1(continued)JURISDICTION OFSUBSIDIARYORGANIZATIONIMV Medical Information Division, Inc.Illinois, USABio-Rad Laboratories (India) Private LimitedIndiaDiaMed Scientific Technologies Private LimitedIndiaBio-Rad Haifa Ltd.IsraelBio-Rad Laboratories S.r.l.ItalyBio-Rad Laboratories K.K.JapanBRD K.K.JapanBio-Rad Korea LimitedKoreaBio-Rad Luxembourg S.à.r.l.LuxembourgInternational Marketing Ventures, LimitedMaryland, USAMJ Research, Inc.USABio-Rad S.A.MexicoBio-Rad Laboratories B.V.The NetherlandsBio-Rad Polska Sp. z o.o.PolandBio-Rad Laboratoires-Aparelhos e Reagentes
Hospitalares, LDAPortugalBio-Rad Laboratorii OOORussiaBio-Rad Laboratories (Singapore) Pte. LimitedSingaporeBio-Rad Laboratories (Pty) LimitedSouth AfricaBio-Rad Laboratories S.A.SpainDistr. de Analitica para Medicina IbericaSpainBio-Rad Laboratories ABSwedenDiaMed Holding AGSwitzerlandDiaMed (Schweiz) G.m.b.H.SwitzerlandDiaMed G.m.b.H.SwitzerlandBio-Rad Laboratories AGSwitzerlandBio-Rad Laboratories LimitedThailandDiaMed South East Asia Ltd.ThailandDiaMed Middle East Ltd.UAEBio-Rad Ltd.United KingdomBio-Rad Laboratories Europe LimitedUnited KingdomBio-Rad Laboratories LimitedUnited KingdomBio-Rad Laboratories Deeside Ltd.United KingdomDiaMed (G.B.) LimitedUnited KingdomMJ Geneworks, Inc.Wisconsin, USA   2
*This order and judgment is not binding precedent, except under the doctrines of law of

the case, res judicata, and collateral estoppel. This court generally disfavors the citation of orders

and judgments; nevertheless, an order and judgment may be cited under the terms and conditions

of 10th Cir. R. 36.3.

UNITED STATES COURT OF APPEALS

Filed 6/20/96

TENTH CIRCUIT

MELVIN SAMUEL RAINE,

Plaintiff - Appellant,

v.

BRITT COLLE,

Defendant - Appellee.

No. 95-3386

(D. Ct. No. 95-3436)

(D. Kan.)

ORDER AND JUDGMENT*

Before TACHA, BALDOCK, and BRISCOE, Circuit Judges.

After examining the briefs and the appellate record, this three-judge panel has

determined unanimously that oral argument would not be of material assistance in the

determination of this appeal. See Fed. R. App. P. 34(a); 10th Cir. R. 34.1.9. The cause is

therefore ordered submitted without oral argument.

This appeal is from an order of the district court dismissing pro se appellant

Raine’s action pursuant to 42 U.S.C. § 1983 for failure to state a claim. Plaintiff Raine

argues on appeal that the district court erred in allegedly failing to recognize a
- 2 -

constitutional right under the circumstances alleged in his complaint. We affirm.

Plaintiff’s complaint alleges a deprivation of his constitutional rights in the actions

of an attorney who was paid a retainer for representation and from whom plaintiff heard

nothing for several weeks. All of the factual allegations contained in plaintiff’s complaint

and in plaintiff’s brief on appeal relate to the relationship between the attorney and

plaintiff. Plaintiff has failed to allege the deprivation of a constitutional right or the

violation of a federal law of a defendant acting under color of state law. The relationship

between plaintiff and his attorney involves no action by a state governmental official. 

Plaintiff’s attorney was acting in a purely private capacity. Thus, we agree with the

district court that plaintiff has failed to state a claim for relief and affirm the dismissal of

this action. We GRANT in forma pauperis status and AFFIRM.

The mandate shall issue forthwith.

ENTERED FOR THE COURT,

Deanell Reece Tacha

Circuit Judge
97-385.

#### State v. Williams.

Franklin App. No. 94APA03-281. On motion for leave to file delayed appeal. Motion denied.

Lundberg Stratton, J., dissents.